Literature DB >> 8123170

Test for chemotherapeutic sensitivity of cerebral gliomas: use of the colorimetric MTT assay.

J C Tonn, G Nikkhah, J L Darling, W Schachenmayr.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8123170     DOI： 10.1007/bf01324706

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  7 in total

1.  Brain tissue concentration of mitoxantrone in the rat in relation to in vitro chemosensitivity of malignant human intracranial tumors--preliminary results.

Authors:  J C Tonn; R Schönmayr; R Braun; H P Kraemer; G Ehninger
Journal:  J Chemother       Date:  1989-07       Impact factor: 1.714

Review 2.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

Review 3.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Pharmacologic pitfalls in the human tumor clonogenic assay.

Authors:  D S Alberts; J Einspahr; R Ludwig; S E Salmon
Journal:  Recent Results Cancer Res       Date:  1984

5.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; R Schönmayr; W Schachenmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

Review 6.  Clonogenic and nonclonogenic in vitro chemosensitivity assays.

Authors:  L M Weisenthal; M E Lippman
Journal:  Cancer Treat Rep       Date:  1985-06

Review 7.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.